IN8bio, Inc. (INAB)
1.05
+0.06
(+6.50%)
USD |
NASDAQ |
Oct 23, 16:00
1.04
-0.01
(-0.95%)
After-Hours: 20:00
IN8bio Price : 1.05 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.02 | 1.079 | 1.018 | 1.05 | 10300.00 |
| Oct 22, 2026 | 1.06 | 1.090 | 0.9758 | 0.9859 | 44139.00 |
| Oct 21, 2026 | 1.16 | 1.16 | 1.050 | 1.09 | 32212.00 |
| Oct 20, 2026 | 1.10 | 1.175 | 1.10 | 1.14 | 2377.00 |
| Oct 19, 2026 | 1.11 | 1.174 | 1.07 | 1.09 | 21753.00 |
| Oct 16, 2026 | 1.17 | 1.18 | 1.06 | 1.11 | 31728.00 |
| Oct 15, 2026 | 1.209 | 1.235 | 1.17 | 1.185 | 9828.00 |
| Oct 14, 2026 | 1.185 | 1.23 | 1.135 | 1.20 | 73613.00 |
| Oct 13, 2026 | 1.25 | 1.26 | 1.18 | 1.18 | 64708.00 |
| Oct 12, 2026 | 1.358 | 1.36 | 1.225 | 1.23 | 39320.00 |
| Oct 09, 2026 | 1.36 | 1.38 | 1.34 | 1.34 | 13053.00 |
| Oct 08, 2026 | 1.40 | 1.40 | 1.33 | 1.38 | 22319.00 |
| Oct 07, 2026 | 1.38 | 1.41 | 1.36 | 1.40 | 20687.00 |
| Oct 06, 2026 | 1.425 | 1.45 | 1.35 | 1.39 | 45589.00 |
| Oct 05, 2026 | 1.43 | 1.45 | 1.38 | 1.42 | 107128.0 |
| Oct 02, 2026 | 1.42 | 1.46 | 1.342 | 1.40 | 39473.00 |
| Oct 01, 2026 | 1.36 | 1.46 | 1.36 | 1.40 | 78466.00 |
| Sep 30, 2026 | 1.31 | 1.362 | 1.31 | 1.33 | 30299.00 |
| Sep 29, 2026 | 1.28 | 1.30 | 1.27 | 1.295 | 62213.00 |
| Sep 28, 2026 | 1.19 | 1.30 | 1.19 | 1.24 | 74348.00 |
| Sep 25, 2026 | 1.18 | 1.27 | 1.17 | 1.20 | 67590.00 |
| Sep 24, 2026 | 1.111 | 1.25 | 1.10 | 1.19 | 180130.0 |
| Sep 23, 2026 | 1.15 | 1.15 | 1.10 | 1.10 | 22606.00 |
| Sep 22, 2026 | 1.06 | 1.16 | 1.06 | 1.14 | 41926.00 |
| Sep 21, 2026 | 1.09 | 1.11 | 1.06 | 1.06 | 13775.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| Price to Book Value | 0.5634 |
| Earnings Yield | -177.4% |
| Market Cap | 10.35M |